ArticleBMC cancer2022

Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinoma.

Tien-Hua Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.